STAT3, a key regulator of cell-to-cell communication in the heart

Cardiovascular Research

Volumn 102, Issue 2, 2014, Pages 281-289

  Haghikia, Arash ^a   Ricke Hoch, Melanie ^a   Stapel, Britta ^a   Gorst, Irina ^a   Hilfiker Kleiner, Denise ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angiogenesis; Cardiomyopathy; Fibrosis; Inflammation; STAT3

Indexed keywords

DNA METHYLTRANSFERASE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEU DIFFERENTIATION FACTOR; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ACETYLATION; CARDITIS; CELL COMMUNICATION; CONSENSUS SEQUENCE; DNA METHYLATION; ENDOTHELIUM CELL; ENERGY YIELD; FIBROBLAST; GENE REPRESSION; GENE SILENCING; HEART BLOOD VESSEL; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; MICROENVIRONMENT; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULAR ENDOTHELIUM; ANGIOGENESIS; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84899111807     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu034     Document Type: Review

References (105)

1. Boengler K Hilfiker-Kleiner D Heusch G Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010;105:771-785
2. Elschami M Scherr M Philippens B Gerardy-Schahn R. Reduction of STAT3 expression induces mitochondrial dysfunction and autophagy in cardiac HL-1 cells. Eur J Cell Biol 2013;92:21-29
3. Heusch G Musiolik J Gedik N Skyschally A. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/ reperfusion. Circul Res 2011;109:1302-1308
4. Wegrzyn J Potla R ChwaeYJ Sepuri NB ZhangQ KoeckTet al. Function of mitochondrial Stat3 in cellular respiration. Science 2009;323:793-797
5. Haghikia A Stapel B Hoch M Hilfiker-Kleiner D. STAT3 and cardiac remodeling. Heart Fail Rev 2011;16:35-47
6. Hilfiker-Kleiner D Hilfiker A Fuchs M Kaminski K Schaefer A Schieffer B et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth control of interstitial matrix deposition and heart protection from ischemic injury. Circul Res 2004;95:187-195
7. Zouein FA Kurdi M Booz GW. Dancing rhinos in stilettos: The amazing saga of the genomic and nongenomic actions of STAT3 in the heart. Jak-Stat 2013;2:e24352
8. Zachary I Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001;49:568-581
9. Wang M Zhang W Crisostomo P Markel T Meldrum KK Fu XY et al. Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circul Physiol 2007;293:H2101-e22108
10. Wang SG Xu Y Chen JD Yang CH Chen XH. Astragaloside IV stimulates angiogenesis and increases nitric oxide accumulation via JAK2/STAT3 and ERK1/2 pathway. Molecules 2013;18:12809-12819
11. Waxman AB Mahboubi K Knickelbein RG Mantell LL Manzo N Pober JS et al. Interleukin-11 and interleukin-6 protect cultured human endothelial cells from H2O2-induced cell death. Am J Respir Cell Mol Biol 2003;29:513-522
12. Fritzenwanger M Kuethe F Haase D Jandt E Figulla HR. Cardiotrophin-1 induces monocyte chemoattractant protein-1 synthesis in human umbilical vein endothelial cells. Cytokine 2006;33:46-51
13. Fritzenwanger M Meusel K Foerster M Kuethe F Krack A Figulla HR. Cardiotrophin-1 induces interleukin-6 synthesis in human umbilical vein endothelial cells. Cytokine 2006; 36:101-106
14. Lee JE Lee AS Kim DH Jung YJ Lee S Park BH et al. Janex-1 a JAK3 inhibitor ameliorates tumor necrosis factor-Alpha-induced expression of cell adhesion molecules and improves myocardial vascular permeability in endotoxemic mice. Int J Mol Med 2012; 29:864-870
15. Iwakura T Mohri T Hamatani T Obana M Yamashita T Maeda M et al. STAT3/Pim-1 signaling pathway plays a crucial role in endothelial differentiation of cardiac resident Sca-1+ cells both in vitro and in vivo. J Mol Cell Cardiol 2011;51:207-214
16. Dai B Cui M Zhu M Su WL Qiu MC Zhang H. STAT1/3 and ERK1/2 synergistically regulate cardiac fibrosis induced by high glucose. Cell Physiol Biochem 2013;32:960-971
17. Mir SA Chatterjee A Mitra A Pathak K Mahata SK Sarkar S. Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J Biol Chem 2012;287: 2666-2677
18. Skoumal R Toth M Serpi R Rysa J Leskinen H Ulvila J et al. Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity. J Mol Cell Cardiol 2011;50:634-641
19. Haghikia A Missol-Kolka E Tsikas D Venturini L Brundiers S Castoldi M et al. Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: A key role for ubiquitinconjugating enzymes. Eur Heart J 2011;32:1287-1297
20. Hilfiker-Kleiner D Limbourg A Drexler H. STAT3-mediated activation of myocardial capillary growth. Trends Cardiovasc Med 2005;15:152-157
21. Hilfiker-Kleiner D Kaminski K Podewski E Bonda T Schaefer A Sliwa K et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128:589-600
22. Hilfiker-Kleiner D Shukla P Klein G Schaefer A Stapel B Hoch M et al. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation left ventricular rupture and adverse outcomein subacute myocardial infarction. Circulation 2010;122:145-155
23. Hoch M Fischer P Stapel B Missol-Kolka E Sekkali B Scherr M et al. Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies. Cell Stem Cell 2011;9:131-143.
24. Jacoby JJ Kalinowski A Liu MG Zhang SS Gao Q Chai GX et al. Cardiomyocyterestricted knockout of STAT3 results in higher sensitivity to inflammation cardiac fibrosis and heart failure with advanced age. Proc Natl Acad Sci USA 2003;100: 12929-12934
25. Hilfiker-Kleiner D Hilfiker A Drexler H. Many good reasons to have STAT3 in the heart. Pharmacol Therap 2005;107:131-137
26. Darnell JE Jr Kerr IM Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264: 1415-1421
27. Zhong ZWenZ Darnell JE Jr. Stat3: A STAT family memberactivated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264:95-98
28. Schindler CW. Series introduction. JAK-STAT signaling in human Disease. J Clin Invest 2002;109:1133-1137
29. Ng DC Court NW dos Remedios CG Bogoyevitch MA. Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts. Cardiovasc Res 2003;57:333-346
30. Podewski EK Hilfiker-Kleiner D Hilfiker A Morawietz H Lichtenberg AWollert KC et al. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 2003; 107:798-802
31. Stephanou A Brar BK Scarabelli TM Jonassen AK Yellon DM Marber MS et al. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem 2000;275:10002-10008
32. Santos CI Costa-Pereira AP. Signal transducers and activators of transcription-from cytokine signalling to cancer biology. Biochim Biophys Acta 2011;1816:38-49
33. Fairweather D Frisancho-Kiss S Yusung SA Barrett MA Davis SE SteeleRA et al. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol 2005;174:261-269
34. El-Adawi H Deng L Tramontano A Smith S Mascareno E Ganguly K et al. The functional role of the JAK-STATpathway in post-infarction remodeling. Cardiovasc Res 2003; 57:129-138
35. Fischer P Hilfiker-Kleiner D. Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br J Pharmacol 2008;153(Suppl. 1): S414-S427
36. Kirito K Nakajima KWatanabe T UchidaM Tanaka M Ozawa K et al. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood 2002;99:102-110
37. Li Y Takemura G Okada H Miyata S Maruyama R Li L et al. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 2006;71:684-694
38. McGaffin KR Zou B McTiernan CF ODonnell CP. Leptin attenuates cardiac apoptosis after chronic ischaemic injury. Cardiovasc Res 2009;83:313-324
39. Yang R Barouch LA. Leptin signaling and obesity: Cardiovascular consequences. Circul Res 2007;101:545-559
40. Kodama H Fukuda K Pan J Makino S Sano M Takahashi T et al. Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes. Circul Res 1998;82: 244-250
41. Levy DE Lee CK. What does Stat3 do?. J Clin Invest 2002;109:1143-1148
42. Aggarwal BB Kunnumakkara AB Harikumar KB Gupta SR Tharakan ST Koca C et al. Signal transducer and activator of transcription-3 inflammation and cancer: Howintimate is the relationship?. Ann N Y Acad Sci 2009;1171:59-76
43. Decker T Kovarik P. Serine phosphorylation of STATs. Oncogene 2000;19:2628-2637
44. Fischer P Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: The gp130-STAT axis. Basic Res Cardiol 2007;102:393-411
45. Lee H Zhang P Herrmann A Yang C Xin HWang Z et al. Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in Demethylation. Proc Natl Acad Sci USA 2012;109:7765-7769
46. Ray S Lee C Hou T Boldogh I Brasier AR. Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution. Nucleic Acids Res 2008;36:4510-4520
47. Li L Cheung SH Evans EL Shaw PE. Modulation of gene expression and tumor cell growth by redox modification of STAT3. Cancer Res 2010;70:8222-8232
48. Szczepanek K Lesnefsky EJ LarnerAC. Multi-Tasking: Nuclear transcription factors with novel roles in the mitochondria. Trends Cell Biol 2012;22:429-437
49. Brutsaert DL Fransen P Andries LJ De KeulenaerGW Sys SU. Cardiac endothelium and myocardial function. Cardiovasc Res 1998;38:281-290
50. Brutsaert DL. Cardiac endothelial-myocardial signaling: Its role in cardiac growth contractile performance and rhythmicity. Physiol Rev 2003;83:59-115
51. Kuruvilla L Kartha CC. Molecular mechanisms in endothelial regulation of cardiac function. Mol Cell Biochem 2003;253:113-123
52. Osugi T Oshima Y Fujio Y Funamoto M Yamashita A Negoro S et al. Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. J Biol Chem 2002;277:6676-6681
53. Hoeben A Landuyt B Highley MS Wildiers H Van Oosterom AT De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549-580
54. Tammela T Enholm B Alitalo K Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005;65:550-563
55. Shabbir A Zisa D Lin H Mastri M Roloff G Suzuki G et al. Activation of host tissue trophic factors through JAK-STAT3 signaling: A mechanism of mesenchymal stem cellmediated cardiac repair. Am J Physiol Heart Circul Physiol 2010;299:H1428-H1438
56. WangW Kagaya Y Asaumi Y Fukui S Takeda M Shimokawa H. Protective effects of recombinant human erythropoietin against pressure overload-induced left ventricular remodeling and premature death in mice. Tohoku J Exp Med 2011;225:131-143
57. Westenbrink BD Ruifrok WP Voors AA Tilton RG van Veldhuisen DJ Schoemaker RG et al. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc Res 2010;87:30-39
58. Harada M Qin Y Takano H Minamino T Zou Y Toko H et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005;11:305-311
59. Chen YH Xu X Sheng MJ Zheng Z Gu Q. Effects of asymmetric dimethylarginine on bovine retinal capillary endothelial cell proliferation reactive oxygen species production permeability intercellular adhesion molecule-1 and occludin expression. Mol Vis 2011;17:332-340
60. Nicholson TB Chen T Richard S. The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol Res 2009;60:466-474
61. Toescu V Nuttall SL Martin U Kendall MJ Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol 2002;57:609-613
62. Patten IS Rana S Shahul S Rowe GC Jang C Liu L et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012;485:333-338
63. Halkein J Tabruyn SP Ricke-Hoch M Haghikia A Nguyen NQ Scherr M et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013;123:2143-2154
64. Sliwa K Blauwet L Tibazarwa K Libhaber E Smedema JP Becker A et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof-of-concept pilot study. Circulation 2010;121:1465-1473
65. Turchinovich AWeiz L Burwinkel B. Extracellular miRNAs: The mystery of their origin and function. Trends Biochem Sci 2012;37:460-465
66. Kosaka N Iguchi H Ochiya T. Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010;101:2087-2092
67. Lemmens K Doggen K De Keulenaer GW. Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy.AmJ Physiol Heart Circul Physiol 2011;300:H931-H942
68. Shapiro P. Ras-MAP kinase signaling pathways and control of cell proliferation: Relevance to cancer therapy. Crit Rev Clin Lab Sci 2002;39:285-330
69. Hedhli N Huang Q Kalinowski A Palmeri M Hu X Russell RR et al. Endotheliumderived neuregulin protects the heart against ischemic injury. Circulation 2011;123: 2254-2262
70. Lemmens K Segers VF Demolder M De KeulenaerGW. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-Talk. J Biol Chem 2006;281: 19469-19477
71. Odiete O Hill MF Sawyer DB. Neuregulin in cardiovascular development and disease. Circul Res 2012;111:1376-1385
72. Obana M Maeda M Takeda K Hayama A Mohri T Yamashita T et al. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction. Circulation 2010;121:684-691
73. Krishnamurthy P Thal M Verma S Hoxha E Lambers E Ramirez V et al. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circul Res 2011;109:1280-1289
74. Cardinale D Colombo A Lamantia G Colombo N Civelli M De Giacomi G et al. Anthracycline-induced cardiomyopathy: Clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 2010;55:213-220
75. Frangogiannis NG Perrard JL Mendoza LH Burns AR LindseyML BallantyneCMet al. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 1998;98:687-698
76. Mohri T Fujio Y Obana M Iwakura T Matsuda K MaedaMet al. Signals through glycoprotein 130 regulate the endothelial differentiation of cardiac stem cells. Arterioscler Thromb Vascular Biology 2009;29:754-760
77. Mohri T Fujio Y Maeda M Ito T Iwakura T Oshima Y et al. Leukemia inhibitory factor induces endothelial differentiation in cardiac stem cells. J Biol Chem 2006;281: 6442-6447
78. Cai B Li JWang J Luo X Ai J Liu Y et al. microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling. Stem Cells 2012;30:1746-1755
79. Maki JM Rasanen J Tikkanen H Sormunen R Makikallio K Kivirikko KI et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms cardiovascular dysfunction and perinatal death in mice. Circulation 2002;106:2503-2509
80. Sivakumar P Gupta S Sarkar S Sen S. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human Dilated cardiomyopathy. Mol Cell Biochem 2008;307: 159-167
81. Siwik DA Chang DL Colucci WS. Interleukin-1beta and tumor necrosis factor-Alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circul Res 2000;86:1259-1265
82. Mishra PK Givvimani S Chavali V Tyagi SC. Cardiac matrix: A clue for future therapy. Biochim Biophys Acta 2013;1832:2271-2276
83. Kassiri Z Oudit GY Sanchez O Dawood F Mohammed FF Nuttall RK et al. Combination of tumor necrosis factor-Alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circul Res 2005;97:380-390
84. Melendez GC McLarty JL Levick SPDu Y Janicki JS Brower GL. Interleukin 6 mediates myocardial fibrosis concentric hypertrophy and diastolic dysfunction in rats. Hypertension 2010;56:225-231
85. Deten A Volz HC BriestWZimmerHG. Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats. Mol Cell Biochem 2003;242: 47-55
86. Palmieri EA Benincasa G Di Rella F Casaburi C Monti MG De Simone Get al. Differential expression of TNF-Alpha IL-6 and IGF-1 by graded mechanical stress in normal rat myocardium. Am J Physiol Heart Circul Physiol 2002;282:H926-H934
87. Pan J Fukuda K Saito M Matsuzaki J Kodama H Sano M et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circul Res 1999;84:1127-1136
88. Sano M Fukuda K Kodama H TakahashiT KatoTHakunoDet al. Autocrine/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation. Biochem Biophys Res Commun 2000;269:798-802
89. Sano M Fukuda K Kodama H Pan J Saito M Matsuzaki J et al. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 2000;275:29717-29723
90. Burger A Benicke M Deten A Zimmer HG. Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am J Physiol Heart Circul Physiol 2001;281:H14-H21
91. Chen C Du J FengW Song Y Lu Z Xu M et al. beta-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCdelta/p38 MAPK signalling in neonatal mouse cardiac fibroblasts. Br J Pharmacol 2012;166:676-688
92. Ono K Matsumori A Shioi T Furukawa Y Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 1998;98:149-156
93. Bujak M Dobaczewski M Chatila K Mendoza LH Li N Reddy A et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 2008;173:57-67
94. Frangogiannis NG Lindsey ML Michael LH Youker KA Bressler RB Mendoza LHet al. Resident cardiacmast cells degranulate and release preformed TNF-Alpha initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 1998;98:699-710
95. Elias JA Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol 1990;145:161-166
96. Jirik FR Podor TJ Hirano T Kishimoto T Loskutoff DJ Carson DA et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989;142:144-147
97. Cicco NA Lindemann A Content J Vandenbussche P Lubbert M Gauss J et al. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: Role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-Alpha. Blood 1990;75:2049-2052
98. Sanceau J Kaisho T Hirano T Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-Alpha in monocytic cells involves cooperation between interferon regulatory factor-1 NF kappa B and Sp1 transcription factors. J Biol Chem 1995;270:27920-27931
99. Lecour S Suleman N Deuchar GA Somers S Lacerda L Huisamen B et al. Pharmacological preconditioning with tumor necrosis factor-Alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 2005;112: 3911-3918
100. Riley JK Takeda K Akira S Schreiber RD. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for antiinflammatory action. J Biol Chem 1999;274:16513-16521
101. Takeda K Clausen BE Kaisho T Tsujimura T Terada N Forster I et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49
102. Manukyan MC Alvernaz CH Poynter JA Wang Y Brewster BD Weil BR et al. Interleukin-10 protects the ischemic heart from reperfusion injury via the STAT3 pathway. Surgery 2011;150:231-239
103. Murray PJ. STAT3-mediated anti-inflammatory signalling. Biochem Soc Transactions2006; 34:1028-1031
104. de Jong PR Schadenberg AW van Den Broek T Beekman JM van Wijk F Coffer PJ et al. STAT3 regulates monocyte TNF-Alpha production in systemic inflammation caused by cardiac surgery with cardiopulmonary bypass. PLoS One 2012;7:e35070
105. Gwechenberger M Mendoza LH Youker KA Frangogiannis NG Smith CW Michael LH et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999;99:546-551